Northwestern University in Evanston, Ill., will lead a project with eight other universities to integrate patient-reported outcomes into electronic health records as part of a grant from the National Institutes of Health.
Data Points for the week of Sept. 26, 2016, covered the following topics: Clinical trials and the number of trials underway, penalties for not reporting results, and the percentage of cancer patients who participate in clinical trials.
Both Democrat Hillary Clinton and Republican Donald Trump have reportedly tapped policy experts with some healthcare experience for their transition teams.
Hearings and legislation are focused on recent issues with the Affordable Care Act as lawmakers also discuss how to continue funding federal agencies.
After more than a decade of asking why factors such as race, ethnicity, income, gender and sexual orientation often correlate with worse health and healthcare quality for so many Americans, perhaps the biggest question is what can healthcare providers do about it.
Abbott backpedaled on the deal in April because of concerns about the accuracy of covenants, warranties and various representations made by Alere in the merger agreement.
Dr. John Gallin, longtime director of the National Institutes of Health's research hospital, has been moved to a new role months after a report sharply claimed the Clinical Center prioritized research over patient safety.
Two new centers will study the impact of a person's surrounding environment—the family, local community, the healthcare system—on health, rather than homing in on individual factors.
The government needs to better protect consumers from high prescription medication costs by setting tougher standards for companies seeking drug exclusivity protection for their brand name products, according to a study.
National Institutes of Health Director Dr. Anthony Fauci said Sunday that the Zika virus could "hang around" the U.S. for a year or two.
HHS Secretary Sylvia Mathews Burwell said she will divert federal funds to support efforts to develop a Zika vaccine.
The head of the National Institute of Allergy and Infectious Diseases said Friday that preparations for the second phase of vaccine testing may be impossible without more money, which will be difficult to obtain with Congress on a weeks-long break.